These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25646885)

  • 1. Clinical trial watch: reports from the AASLD Liver Meeting®, Boston, November 2014.
    Londoño MC; Abraldes JG; Altamirano J; Decaens T; Forns X
    J Hepatol; 2015 May; 62(5):1196-203. PubMed ID: 25646885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Trial Watch: Reports from the Liver Meeting®, AASLD, San Francisco, November 2015.
    Wiegand J; van Bömmel F; Duarte-Rojo A; Altamirano J; Abraldes JG; Villanueva A; Berg T
    J Hepatol; 2016 Jun; 64(6):1428-45. PubMed ID: 26902945
    [No Abstract]   [Full Text] [Related]  

  • 3. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program.
    Garcia-Tsao G; Lim JK;
    Am J Gastroenterol; 2009 Jul; 104(7):1802-29. PubMed ID: 19455106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment options in patients with decompensated cirrhosis, pre- and post-transplantation.
    Gambato M; Lens S; Navasa M; Forns X
    J Hepatol; 2014 Nov; 61(1 Suppl):S120-31. PubMed ID: 25443340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy of hepatitis C: patients with cirrhosis.
    Schalm SW; Fattovich G; Brouwer JT
    Hepatology; 1997 Sep; 26(3 Suppl 1):128S-132S. PubMed ID: 9305677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: a multicenter experience.
    Coilly A; Roche B; Dumortier J; Leroy V; Botta-Fridlund D; Radenne S; Pageaux GP; Si-Ahmed SN; Guillaud O; Antonini TM; Haïm-Boukobza S; Roque-Afonso AM; Samuel D; Duclos-Vallée JC
    J Hepatol; 2014 Jan; 60(1):78-86. PubMed ID: 23994384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease.
    Reddy SK; Steel JL; Chen HW; DeMateo DJ; Cardinal J; Behari J; Humar A; Marsh JW; Geller DA; Tsung A
    Hepatology; 2012 Jun; 55(6):1809-19. PubMed ID: 22183968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry.
    Taniguchi M
    Clin Transpl; 2012; ():41-65. PubMed ID: 23721009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of new direct acting antivirals in transplant recipients and patients with advanced disease.
    Lens S; Mariño Z; Forns X
    Dig Liver Dis; 2014 Dec; 46 Suppl 5():S197-205. PubMed ID: 25458782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergency liver resection for ruptured hepatocellular carcinoma complicating cirrhosis.
    Chiappa A; Zbar A; Audisio RA; Paties C; Bertani E; Staudacher C
    Hepatogastroenterology; 1999; 46(26):1145-50. PubMed ID: 10370682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of compensated viral B and D cirrhosis.
    Gheorghe L; Iacob S; Simionov I; Vadan R; Gheorghe C; Iacob R; Parvulescu I; Constantinescu I
    Rom J Gastroenterol; 2005 Dec; 14(4):329-35. PubMed ID: 16400347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical Implications of Inflammation and Immunity in Acute and Chronic Liver Disease: Advances in Diagnosis, Treatment and Clinical Practice. AASLD Liver Meeting, Boston, November 7-11, 2014].
    Pár A
    Orv Hetil; 2015 May; 156(21):869-72. PubMed ID: 26038995
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiviral therapy for hepatitis B virus-related decompensated cirrhosis.
    Wang JY
    J Dig Dis; 2012 Nov; 13(11):555-7. PubMed ID: 23107441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of hepatitis C.
    Westbrook RH; Dusheiko G
    J Hepatol; 2014 Nov; 61(1 Suppl):S58-68. PubMed ID: 25443346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma after sustained viral response to interferon and ribavirin therapy in cirrhosis secondary to chronic hepatitis C.
    Khokhar N; Niazi TK; Qureshi MO
    J Coll Physicians Surg Pak; 2013 Oct; 23(10):699-702. PubMed ID: 24112253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there sufficient evidence to recommend antiviral therapy in hepatitis C?
    van der Meer AJ; Wedemeyer H; Feld JJ; Hansen BE; Manns MP; Zeuzem S; Janssen HL
    J Hepatol; 2014 Jan; 60(1):191-6. PubMed ID: 23973931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].
    Schott E; Bergk A; Berg T
    Z Gastroenterol; 2008 Jan; 46(1):69-80. PubMed ID: 18188819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Trial Watch: Reports from the EASL International Liver Congress (ILC), Vienna, April 2015.
    Gambato M; Villanueva A; Abraldes JG; Altamirano J; Forns X
    J Hepatol; 2015 Sep; 63(3):753-62. PubMed ID: 26095181
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic factors of survival in complicated viral and alcoholic cirrhosis without hepatocellular carcinoma. A retrospective study.
    Spadaro A; Luigiano C; De Caro G; Morace C; Tortorella V; Bonfiglio C; Pagano N; Consolo P; Alibrandi A; Ajello A; Ferraù O; Freni MA
    Minerva Gastroenterol Dietol; 2007 Dec; 53(4):311-9. PubMed ID: 18043549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.